Clinical Trials Directory

Trials / Completed

CompletedNCT03345329

Development of a Molecular Diagnosing Platform for Relieving Periodontal Symptoms

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
General Biologicals Corporation · Industry
Sex
All
Age
25 Years
Healthy volunteers
Accepted

Summary

More than ninety percent of adults in Taiwan are suspected to carry periodontal disease, which causes bad breath, swollen and bleeding gums, plaque and even tooth loss. Half of the patients, however, are ignorance these clinical syndromes because of no obvious pain. In this study, the investigators selected six periodontal disease-associated bacteria strains, including Porphyromonas gingivalis (Pg), Fusobacterium nucleatum (Fn), Actinobacillus actinomycetemcomitans (Aa), Tannerella forsythia (Tf), Treponema denticola (Td) and Prevotella intermedia (Pi) as diagnostic markers. Using real-time PCR and MALDI Biotyper, the investigators will establish the database of oral microorganisms in Taiwanese people, providing periodontal disease clinical markers of high-risk groups and the basis for personal medicine of therapy in the future.

Conditions

Timeline

Start date
2015-10-01
Primary completion
2016-03-30
Completion
2016-09-30
First posted
2017-11-17
Last updated
2017-11-17

Source: ClinicalTrials.gov record NCT03345329. Inclusion in this directory is not an endorsement.